Split History
ETFs Holding ZLCS »    ZLCS Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Zalicus is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain. Co.'s primary product candidate is Z160, an oral N-type calcium channel blocker that Co. is seeking to develop for the treatment of chronic pain. Co.'s other product candidate is Z944, an oral T-type calcium channel blocker that Co. is seeking to develop for the treatment of pain indications. In addition, Co. is performing discovery research and preclinical development activities on its proprietary selective ion channel modulators targeting the Nav1.7 sodium channel as well as N-type and T-type calcium channels, as part of a research collaboration with Hydra Biosciences, Inc. According to our ZLCS split history records, ZLCS has had 1 split.
ZLCS split history picture
ZLCS (ZLCS) has 1 split in our ZLCS split history database. The split for ZLCS took place on October 03, 2013. This was a 1 for 6 reverse split, meaning for each 6 shares of ZLCS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split.

When a company such as ZLCS conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the ZLCS split history from start to finish, an original position size of 1000 shares would have turned into 166.666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ZLCS shares, starting with a $10,000 purchase of ZLCS, presented on a split-history-adjusted basis factoring in the complete ZLCS split history. ZLCS split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/20/2009
End date: 07/15/2014
Start price/share: $4.50
End price/share: $1.18
Dividends collected/share: $0.00
Total return: -73.78%
Average Annual Total Return: -23.53%
Starting investment: $10,000.00
Ending investment: $2,622.60
Years: 4.99
Date Ratio
10/03/20131 for 6
ZLCS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ZSAN Split History
A Split History
AAC Split History
ABC Split History
ABIO Split History
ABMD Split History
ABT Split History
ABV Split History
ACER Split History
ACET Split History

Neuralstem, Inc. (CUR)
Francesca's Holdings Corporation (FRAN)
China Green Agriculture, Inc. (CGA)
Xenetic Biosciences, Inc. (XBIO)
Yuma Energy, Inc. (YUMA)
Avinger, Inc. (AVGR)
Sonoma Pharmaceuticals, Inc. (SOMA)
Hudson Global, Inc. (HSON)
Jaguar Health, Inc. (JAGX)
Cesca Therapeutics Inc. (KOOL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ZLCS Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.